USCA RIA’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SDH
EP
USCA RIA's ARKG Position: Q2 2021 in Review
USCA RIA increased its ARK Genomic Revolution ETF (ARKG) stake by 53% in Q2 2021, buying an estimated $319K and bringing the position to 10,842 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #306.
USCA RIA first reported a position in ARKG in Q4 2020 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.
- USCA RIA held 10,842 shares of ARK Genomic Revolution ETF worth $1M as of Q2 2021.
- USCA RIA bought 3,755 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $319K.
- ARK Genomic Revolution ETF made up 0.06% of USCA RIA's portfolio in Q2 2021, its #306 holding.
- USCA RIA first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 3 quarters since.
- 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.
Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.